Department of Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, Doha, Qatar.
Angiology. 2013 Jan;64(1):26-30. doi: 10.1177/0003319711434054. Epub 2012 Apr 30.
We assessed the prevalence of unrecognized diabetes mellitus (DM) in patients with acute coronary syndrome (ACS) as determined by elevated glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG), and random plasma glucose (RPG) levels. This prospective study recruited 583 patients admitted with ACS without previous diagnosis of DM during 1-year period. Glycosylated hemoglobin was checked for most patients especially those with high values of FPG and or RPG. Patients were classified according to their glycemic state into 123 (21.1%) with DM, 82 (14.1%) with prediabetes, and 57(9.8%) with stress hyperglycemia, while 321 (55%) were classified as nondiabetics. Glycosylated hemoglobin estimation in the setting of ACS was helpful in the diagnosis of DM to eliminate the effect of stress-induced hyperglycemia that might accompany this condition.
我们评估了急性冠脉综合征（ACS）患者中未被识别的糖尿病（DM）的患病率，这些患者的糖化血红蛋白（HbA1c）、空腹血糖（FPG）和随机血糖（RPG）水平升高。这项前瞻性研究在 1 年内招募了 583 名患有 ACS 且之前未被诊断为 DM 的患者。大多数患者，尤其是那些 FPG 和/或 RPG 值较高的患者，都进行了糖化血红蛋白检查。根据血糖状态，患者被分为 123 例（21.1%）糖尿病患者、82 例（14.1%）糖尿病前期患者和 57 例（9.8%）应激性高血糖患者，而 321 例（55%）被归类为非糖尿病患者。在 ACS 情况下进行糖化血红蛋白检测有助于诊断 DM，以消除可能伴随这种情况的应激性高血糖的影响。
